|Eligible applicants||Researchers who belong to a university or research institute outside Japan (academia, pharmaceutical company, bio-tech, start-up, etc.).
Students are not accepted.
1. Autoimmune Diseases
2. Critical Care Medicine
3. Neurodegenerative Diseases
4. Pain and Neuropathy
5. Bone Diseases
6. Drug Discovery Platform Technology
Click here for more details.
The research will be conducted over a period of 1–3 years, depending on the research content. Milestones will be set for each year, and the content of the research will be reviewed as needed based on the research results. After the end of the joint research period under this program, the joint research may be continued or expanded depending on the research results.
|Selection criteria||The proposals to be adopted will be selected based on a comprehensive evaluation of conformity to the requested topics, originality and usefulness of research proposed, research plan viability, and conflict with Asahi Kasei Pharma internal projects.|
|Selection system||Review and selection of proposals will be conducted at a meeting of Asahi Kasei Pharma research specialists.|
Click here to download the application form.
|Contract conclusion||For research projects selected at the 2nd selection, a collaboration agreement will be negotiated between the research facility to which the researcher belongs and Asahi Kasei Pharma. Once a contract is concluded collaborative research can start.|
|Research expenses||50,000–200,000 USD (per project, per year) (including overhead costs, excluding tax) Depending on the research content and stage, we will determine the research expenses based on the research plan agreed upon by both parties.|
|Handling of research findings and Intellectual property right||The ownership of inventions, etc., generated during the course of the collaboration will be determined in accordance with the inventor principle, and a joint or independent application with our company will be considered. We may ask you to purchase, establish preferential negotiation rights, or license intellectual property rights related to the collaboration.|
|Publication of research results||In this research collaboration, priority will be given to securing intellectual property rights (patent applications) depending on the content of the research. For this reason, we may ask you to proceed to research on practical applications without publishing results for a certain period after the contract ends. In addition, we will request notification before you submit a presentation to an academic conference or publish a research paper to discuss the contents and timing of your presentation or publication.|
|Questions and inquiries||
Please refer first to the FAQ section of this web site.
To submit inquiries to us, please use the “Contact us” form on this web site.
Click “Apply” to proceed to the application form.